Reaction
Cutaneous Sarcoidosis reporting signals
As of the last recalculation, Cutaneous Sarcoidosis appears in 418 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is DABRAFENIB (PRR 39.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dabrafenib | 16 | 39.3 | 39.3 |
| Ribavirin | 32 | 26.8 | 26.8 |
| Vemurafenib | 6 | 25.2 | 25.2 |
| Trametinib | 11 | 23.3 | 23.3 |